These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8744)

  • 1. Rebound phenomena in manic patients following physostigmine. Preliminary observations.
    Shopsin B; Janowsky D; Davis J; Gershon S
    Neuropsychobiology; 1975; 1(3):180-7. PubMed ID: 8744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physostigmine in mania.
    Davis KL; Berger PA; Hollister LE; Defraites E
    Arch Gen Psychiatry; 1978 Jan; 35(1):119-22. PubMed ID: 339869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Rebound phenomenon in manic patients following physostigmine: towards an understanding of aminergic mechanisms underlying affective disorders.
    Shopsin B; Janowsky D; Davis J; Gershon S
    Psychopharmacol Bull; 1974 Jul; 10(3):50-1. PubMed ID: 4419431
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
    Davis KL; Berger PA
    Biol Psychiatry; 1978 Feb; 13(1):23-49. PubMed ID: 146524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parasympathetic suppression of manic symptoms by physostigmine.
    Janowsky DS; el-Yousef K; Davis JM; Sekerke HJ
    Arch Gen Psychiatry; 1973 Apr; 28(4):542-7. PubMed ID: 4692153
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinergic reversal of manic symptoms.
    Janowsky DS; el-Yousef MK; Davis JM; Hubbard B; Sekerke HJ
    Lancet; 1972 Jun; 1(7762):1236-7. PubMed ID: 4113219
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholinergic challenges in affective illness: behavioral and neuroendocrine correlates.
    Risch SC; Kalin NH; Janowsky DS
    J Clin Psychopharmacol; 1981 Jul; 1(4):186-92. PubMed ID: 7028800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic reversal of manic symptoms.
    Carroll BJ; Frazer A; Schless A; Mendels J
    Lancet; 1973 Feb; 1(7800):427-8. PubMed ID: 4119737
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenergic-cholinergic imbalance in affective disorders.
    Lancet; 1976 Dec; 2(7999):1342-3. PubMed ID: 63810
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Cholinergic and adrenergic balance in mania and schizophrenia.
    Davis JM; Janowsky D
    Psychopharmacol Bull; 1974 Jul; 10(3):49-50. PubMed ID: 4419332
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognitive functions in manic-depressives: effects of lithium and physostigmine.
    Telford R; Worrall EP
    Br J Psychiatry; 1978 Nov; 133():424-8. PubMed ID: 728691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Role of acetylcholine and dopamine in manic behavior.
    Carroll BJ
    Psychopharmacol Bull; 1974 Jul; 10(3):51-2. PubMed ID: 4419438
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.
    Davis KL; Mohs RC
    Am J Psychiatry; 1982 Nov; 139(11):1421-4. PubMed ID: 6753611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physostigmine temporarily and dramatically reversing acute mania.
    Khouzam HR; Kissmeyer PM
    Gen Hosp Psychiatry; 1996 May; 18(3):203-4. PubMed ID: 8739014
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients.
    Levin HS; Peters BH; Kalisky Z; High WM; von Laufen A; Eisenberg HM; Morrison DP; Gary HE
    Cent Nerv Syst Trauma; 1986; 3(4):333-42. PubMed ID: 3555852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.
    Harvey PD; Endicott JM; Loebel AD
    Bipolar Disord; 2008 Dec; 10(8):900-6. PubMed ID: 19594505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central cardiovascular effects of physostigmine in the cat; possible cholinergic aspects of blood pressure regulation.
    de Wildt DJ; Porsius AJ
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):22-39. PubMed ID: 6119963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral physostigmine treatment of patients with Alzheimer's disease.
    Mohs RC; Davis BM; Johns CA; Mathé AA; Greenwald BS; Horvath TB; Davis KL
    Am J Psychiatry; 1985 Jan; 142(1):28-33. PubMed ID: 3881051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physostigmine-induced epinephrine release in patients with affective disorder.
    Janowsky DS; Risch SC; Ziegler MG; Gillin JC; Huey L; Rausch J
    Am J Psychiatry; 1986 Jul; 143(7):919-21. PubMed ID: 3717437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disappearance of tardive dyskinesia in a manic attack].
    Trelles L; Trelles JO; Castaneda C; Castro C
    Rev Neurol (Paris); 1985; 141(5):415-6. PubMed ID: 2864732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.